Global 53BP1 Antibody Market Growth (Status and Outlook) 2026-2032

May 2026 | 151 pages | ID: G20F59AB0777EN
LP Information

Abstracts

The global 53BP1 Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

The 53BP1 antibody is a mouse, rabbit, pig and human antibody against 53BP1. 53BP1 was recognized in immunohistochemical staining and western blotting.

Growing patient base, launch of novel 53BP1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue for the 53BP1 antibody market.

LPI (LP Information)' newest research report, the “53BP1 Antibody Industry Forecast” looks at past sales and reviews total world 53BP1 Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected 53BP1 Antibody sales for 2026 through 2032. With 53BP1 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 53BP1 Antibody industry.

This Insight Report provides a comprehensive analysis of the global 53BP1 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on 53BP1 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 53BP1 Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 53BP1 Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 53BP1 Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of 53BP1 Antibody market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Monoclonal
• Polyclonal

Segmentation by Application:

• Immunochemistry (IHC)
• Immunofluorescence (IF)
• Immunoprecipitation (IP)
• Western Blot (WB)
• ELISA
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck
• Thermo Fisher Scientific
• Abfrontier
• LifeSpan BioSciences
• GeneTex
• Novus Biologicals
• BosterBio
• Cell Signaling Technology
• BioLegend
• Bethyl Laboratories
• NSJ Bioreagents
• HUABIO
• Affinity Biosciences
• R and D Systems
• Santa Cruz Biotechnology
• OriGene Technologies
• Leading Biology
• Bioassay Technology Laboratory
• Miltenyi Biotec
• Biobyt
• Beyotime

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global 53BP1 Antibody Market Size (2021-2032)
  2.1.2 53BP1 Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for 53BP1 Antibody by Country/Region (2021, 2025 & 2032)
2.2 53BP1 Antibody Segment by Type
  2.2.1 Monoclonal
  2.2.2 Polyclonal
  2.2.3 53BP1 Antibody Market Size by Type
    2.2.3.1 53BP1 Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global 53BP1 Antibody Market Size Market Share by Type (2021-2026)
2.3 53BP1 Antibody Segment by Application
  2.3.1 Immunochemistry (IHC)
  2.3.2 Immunofluorescence (IF)
  2.3.3 Immunoprecipitation (IP)
  2.3.4 Western Blot (WB)
  2.3.5 ELISA
  2.3.6 Others
  2.3.7 53BP1 Antibody Market Size by Application
    2.3.7.1 53BP1 Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.7.2 Global 53BP1 Antibody Market Size Market Share by Application (2021-2026)

3 53BP1 ANTIBODY MARKET SIZE BY PLAYER

3.1 53BP1 Antibody Market Size Market Share by Player
  3.1.1 Global 53BP1 Antibody Revenue by Player (2021-2026)
  3.1.2 Global 53BP1 Antibody Revenue Market Share by Player (2021-2026)
3.2 Global 53BP1 Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 53BP1 ANTIBODY BY REGION

4.1 53BP1 Antibody Market Size by Region (2021-2026)
4.2 Global 53BP1 Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas 53BP1 Antibody Market Size Growth (2021-2026)
4.4 APAC 53BP1 Antibody Market Size Growth (2021-2026)
4.5 Europe 53BP1 Antibody Market Size Growth (2021-2026)
4.6 Middle East & Africa 53BP1 Antibody Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas 53BP1 Antibody Market Size by Country (2021-2026)
5.2 Americas 53BP1 Antibody Market Size by Type (2021-2026)
5.3 Americas 53BP1 Antibody Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC 53BP1 Antibody Market Size by Region (2021-2026)
6.2 APAC 53BP1 Antibody Market Size by Type (2021-2026)
6.3 APAC 53BP1 Antibody Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe 53BP1 Antibody Market Size by Country (2021-2026)
7.2 Europe 53BP1 Antibody Market Size by Type (2021-2026)
7.3 Europe 53BP1 Antibody Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa 53BP1 Antibody by Region (2021-2026)
8.2 Middle East & Africa 53BP1 Antibody Market Size by Type (2021-2026)
8.3 Middle East & Africa 53BP1 Antibody Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL 53BP1 ANTIBODY MARKET FORECAST

10.1 Global 53BP1 Antibody Forecast by Region (2027-2032)
  10.1.1 Global 53BP1 Antibody Forecast by Region (2027-2032)
  10.1.2 Americas 53BP1 Antibody Forecast
  10.1.3 APAC 53BP1 Antibody Forecast
  10.1.4 Europe 53BP1 Antibody Forecast
  10.1.5 Middle East & Africa 53BP1 Antibody Forecast
10.2 Americas 53BP1 Antibody Forecast by Country (2027-2032)
  10.2.1 United States Market 53BP1 Antibody Forecast
  10.2.2 Canada Market 53BP1 Antibody Forecast
  10.2.3 Mexico Market 53BP1 Antibody Forecast
  10.2.4 Brazil Market 53BP1 Antibody Forecast
10.3 APAC 53BP1 Antibody Forecast by Region (2027-2032)
  10.3.1 China 53BP1 Antibody Market Forecast
  10.3.2 Japan Market 53BP1 Antibody Forecast
  10.3.3 Korea Market 53BP1 Antibody Forecast
  10.3.4 Southeast Asia Market 53BP1 Antibody Forecast
  10.3.5 India Market 53BP1 Antibody Forecast
  10.3.6 Australia Market 53BP1 Antibody Forecast
10.4 Europe 53BP1 Antibody Forecast by Country (2027-2032)
  10.4.1 Germany Market 53BP1 Antibody Forecast
  10.4.2 France Market 53BP1 Antibody Forecast
  10.4.3 UK Market 53BP1 Antibody Forecast
  10.4.4 Italy Market 53BP1 Antibody Forecast
  10.4.5 Russia Market 53BP1 Antibody Forecast
10.5 Middle East & Africa 53BP1 Antibody Forecast by Region (2027-2032)
  10.5.1 Egypt Market 53BP1 Antibody Forecast
  10.5.2 South Africa Market 53BP1 Antibody Forecast
  10.5.3 Israel Market 53BP1 Antibody Forecast
  10.5.4 Turkey Market 53BP1 Antibody Forecast
10.6 Global 53BP1 Antibody Forecast by Type (2027-2032)
10.7 Global 53BP1 Antibody Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market 53BP1 Antibody Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Merck Company Information
  11.1.2 Merck 53BP1 Antibody Product Offered
  11.1.3 Merck 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Merck Main Business Overview
  11.1.5 Merck Latest Developments
11.2 Thermo Fisher Scientific
  11.2.1 Thermo Fisher Scientific Company Information
  11.2.2 Thermo Fisher Scientific 53BP1 Antibody Product Offered
  11.2.3 Thermo Fisher Scientific 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Thermo Fisher Scientific Main Business Overview
  11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Abfrontier
  11.3.1 Abfrontier Company Information
  11.3.2 Abfrontier 53BP1 Antibody Product Offered
  11.3.3 Abfrontier 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Abfrontier Main Business Overview
  11.3.5 Abfrontier Latest Developments
11.4 LifeSpan BioSciences
  11.4.1 LifeSpan BioSciences Company Information
  11.4.2 LifeSpan BioSciences 53BP1 Antibody Product Offered
  11.4.3 LifeSpan BioSciences 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 LifeSpan BioSciences Main Business Overview
  11.4.5 LifeSpan BioSciences Latest Developments
11.5 GeneTex
  11.5.1 GeneTex Company Information
  11.5.2 GeneTex 53BP1 Antibody Product Offered
  11.5.3 GeneTex 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 GeneTex Main Business Overview
  11.5.5 GeneTex Latest Developments
11.6 Novus Biologicals
  11.6.1 Novus Biologicals Company Information
  11.6.2 Novus Biologicals 53BP1 Antibody Product Offered
  11.6.3 Novus Biologicals 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Novus Biologicals Main Business Overview
  11.6.5 Novus Biologicals Latest Developments
11.7 BosterBio
  11.7.1 BosterBio Company Information
  11.7.2 BosterBio 53BP1 Antibody Product Offered
  11.7.3 BosterBio 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 BosterBio Main Business Overview
  11.7.5 BosterBio Latest Developments
11.8 Cell Signaling Technology
  11.8.1 Cell Signaling Technology Company Information
  11.8.2 Cell Signaling Technology 53BP1 Antibody Product Offered
  11.8.3 Cell Signaling Technology 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Cell Signaling Technology Main Business Overview
  11.8.5 Cell Signaling Technology Latest Developments
11.9 BioLegend
  11.9.1 BioLegend Company Information
  11.9.2 BioLegend 53BP1 Antibody Product Offered
  11.9.3 BioLegend 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 BioLegend Main Business Overview
  11.9.5 BioLegend Latest Developments
11.10 Bethyl Laboratories
  11.10.1 Bethyl Laboratories Company Information
  11.10.2 Bethyl Laboratories 53BP1 Antibody Product Offered
  11.10.3 Bethyl Laboratories 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Bethyl Laboratories Main Business Overview
  11.10.5 Bethyl Laboratories Latest Developments
11.11 NSJ Bioreagents
  11.11.1 NSJ Bioreagents Company Information
  11.11.2 NSJ Bioreagents 53BP1 Antibody Product Offered
  11.11.3 NSJ Bioreagents 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 NSJ Bioreagents Main Business Overview
  11.11.5 NSJ Bioreagents Latest Developments
11.12 HUABIO
  11.12.1 HUABIO Company Information
  11.12.2 HUABIO 53BP1 Antibody Product Offered
  11.12.3 HUABIO 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 HUABIO Main Business Overview
  11.12.5 HUABIO Latest Developments
11.13 Affinity Biosciences
  11.13.1 Affinity Biosciences Company Information
  11.13.2 Affinity Biosciences 53BP1 Antibody Product Offered
  11.13.3 Affinity Biosciences 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Affinity Biosciences Main Business Overview
  11.13.5 Affinity Biosciences Latest Developments
11.14 R and D Systems
  11.14.1 R and D Systems Company Information
  11.14.2 R and D Systems 53BP1 Antibody Product Offered
  11.14.3 R and D Systems 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 R and D Systems Main Business Overview
  11.14.5 R and D Systems Latest Developments
11.15 Santa Cruz Biotechnology
  11.15.1 Santa Cruz Biotechnology Company Information
  11.15.2 Santa Cruz Biotechnology 53BP1 Antibody Product Offered
  11.15.3 Santa Cruz Biotechnology 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Santa Cruz Biotechnology Main Business Overview
  11.15.5 Santa Cruz Biotechnology Latest Developments
11.16 OriGene Technologies
  11.16.1 OriGene Technologies Company Information
  11.16.2 OriGene Technologies 53BP1 Antibody Product Offered
  11.16.3 OriGene Technologies 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 OriGene Technologies Main Business Overview
  11.16.5 OriGene Technologies Latest Developments
11.17 Leading Biology
  11.17.1 Leading Biology Company Information
  11.17.2 Leading Biology 53BP1 Antibody Product Offered
  11.17.3 Leading Biology 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 Leading Biology Main Business Overview
  11.17.5 Leading Biology Latest Developments
11.18 Bioassay Technology Laboratory
  11.18.1 Bioassay Technology Laboratory Company Information
  11.18.2 Bioassay Technology Laboratory 53BP1 Antibody Product Offered
  11.18.3 Bioassay Technology Laboratory 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 Bioassay Technology Laboratory Main Business Overview
  11.18.5 Bioassay Technology Laboratory Latest Developments
11.19 Miltenyi Biotec
  11.19.1 Miltenyi Biotec Company Information
  11.19.2 Miltenyi Biotec 53BP1 Antibody Product Offered
  11.19.3 Miltenyi Biotec 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.19.4 Miltenyi Biotec Main Business Overview
  11.19.5 Miltenyi Biotec Latest Developments
11.20 Biobyt
  11.20.1 Biobyt Company Information
  11.20.2 Biobyt 53BP1 Antibody Product Offered
  11.20.3 Biobyt 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.20.4 Biobyt Main Business Overview
  11.20.5 Biobyt Latest Developments
11.21 Beyotime
  11.21.1 Beyotime Company Information
  11.21.2 Beyotime 53BP1 Antibody Product Offered
  11.21.3 Beyotime 53BP1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.21.4 Beyotime Main Business Overview
  11.21.5 Beyotime Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. 53BP1 Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. 53BP1 Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal
Table 4. Major Players of Polyclonal
Table 5. 53BP1 Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global 53BP1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 7. Global 53BP1 Antibody Market Size Market Share by Type (2021-2026)
Table 8. 53BP1 Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global 53BP1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 10. Global 53BP1 Antibody Market Size Market Share by Application (2021-2026)
Table 11. Global 53BP1 Antibody Revenue by Player (2021-2026) & ($ millions)
Table 12. Global 53BP1 Antibody Revenue Market Share by Player (2021-2026)
Table 13. 53BP1 Antibody Key Players Head office and Products Offered
Table 14. 53BP1 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global 53BP1 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 18. Global 53BP1 Antibody Market Size Market Share by Region (2021-2026)
Table 19. Global 53BP1 Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global 53BP1 Antibody Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas 53BP1 Antibody Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas 53BP1 Antibody Market Size Market Share by Country (2021-2026)
Table 23. Americas 53BP1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas 53BP1 Antibody Market Size Market Share by Type (2021-2026)
Table 25. Americas 53BP1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas 53BP1 Antibody Market Size Market Share by Application (2021-2026)
Table 27. APAC 53BP1 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC 53BP1 Antibody Market Size Market Share by Region (2021-2026)
Table 29. APAC 53BP1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC 53BP1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe 53BP1 Antibody Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe 53BP1 Antibody Market Size Market Share by Country (2021-2026)
Table 33. Europe 53BP1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe 53BP1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa 53BP1 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa 53BP1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa 53BP1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of 53BP1 Antibody
Table 39. Key Market Challenges & Risks of 53BP1 Antibody
Table 40. Key Industry Trends of 53BP1 Antibody
Table 41. Global 53BP1 Antibody Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global 53BP1 Antibody Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global 53BP1 Antibody Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global 53BP1 Antibody Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Merck Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 46. Merck 53BP1 Antibody Product Offered
Table 47. Merck 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Merck Main Business
Table 49. Merck Latest Developments
Table 50. Thermo Fisher Scientific Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 51. Thermo Fisher Scientific 53BP1 Antibody Product Offered
Table 52. Thermo Fisher Scientific 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Thermo Fisher Scientific Main Business
Table 54. Thermo Fisher Scientific Latest Developments
Table 55. Abfrontier Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 56. Abfrontier 53BP1 Antibody Product Offered
Table 57. Abfrontier 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Abfrontier Main Business
Table 59. Abfrontier Latest Developments
Table 60. LifeSpan BioSciences Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 61. LifeSpan BioSciences 53BP1 Antibody Product Offered
Table 62. LifeSpan BioSciences 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. LifeSpan BioSciences Main Business
Table 64. LifeSpan BioSciences Latest Developments
Table 65. GeneTex Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 66. GeneTex 53BP1 Antibody Product Offered
Table 67. GeneTex 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. GeneTex Main Business
Table 69. GeneTex Latest Developments
Table 70. Novus Biologicals Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 71. Novus Biologicals 53BP1 Antibody Product Offered
Table 72. Novus Biologicals 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Novus Biologicals Main Business
Table 74. Novus Biologicals Latest Developments
Table 75. BosterBio Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 76. BosterBio 53BP1 Antibody Product Offered
Table 77. BosterBio 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. BosterBio Main Business
Table 79. BosterBio Latest Developments
Table 80. Cell Signaling Technology Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 81. Cell Signaling Technology 53BP1 Antibody Product Offered
Table 82. Cell Signaling Technology 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Cell Signaling Technology Main Business
Table 84. Cell Signaling Technology Latest Developments
Table 85. BioLegend Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 86. BioLegend 53BP1 Antibody Product Offered
Table 87. BioLegend 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. BioLegend Main Business
Table 89. BioLegend Latest Developments
Table 90. Bethyl Laboratories Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 91. Bethyl Laboratories 53BP1 Antibody Product Offered
Table 92. Bethyl Laboratories 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Bethyl Laboratories Main Business
Table 94. Bethyl Laboratories Latest Developments
Table 95. NSJ Bioreagents Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 96. NSJ Bioreagents 53BP1 Antibody Product Offered
Table 97. NSJ Bioreagents 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. NSJ Bioreagents Main Business
Table 99. NSJ Bioreagents Latest Developments
Table 100. HUABIO Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 101. HUABIO 53BP1 Antibody Product Offered
Table 102. HUABIO 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. HUABIO Main Business
Table 104. HUABIO Latest Developments
Table 105. Affinity Biosciences Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 106. Affinity Biosciences 53BP1 Antibody Product Offered
Table 107. Affinity Biosciences 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Affinity Biosciences Main Business
Table 109. Affinity Biosciences Latest Developments
Table 110. R and D Systems Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 111. R and D Systems 53BP1 Antibody Product Offered
Table 112. R and D Systems 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. R and D Systems Main Business
Table 114. R and D Systems Latest Developments
Table 115. Santa Cruz Biotechnology Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 116. Santa Cruz Biotechnology 53BP1 Antibody Product Offered
Table 117. Santa Cruz Biotechnology 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Santa Cruz Biotechnology Main Business
Table 119. Santa Cruz Biotechnology Latest Developments
Table 120. OriGene Technologies Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 121. OriGene Technologies 53BP1 Antibody Product Offered
Table 122. OriGene Technologies 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. OriGene Technologies Main Business
Table 124. OriGene Technologies Latest Developments
Table 125. Leading Biology Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 126. Leading Biology 53BP1 Antibody Product Offered
Table 127. Leading Biology 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Leading Biology Main Business
Table 129. Leading Biology Latest Developments
Table 130. Bioassay Technology Laboratory Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 131. Bioassay Technology Laboratory 53BP1 Antibody Product Offered
Table 132. Bioassay Technology Laboratory 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Bioassay Technology Laboratory Main Business
Table 134. Bioassay Technology Laboratory Latest Developments
Table 135. Miltenyi Biotec Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 136. Miltenyi Biotec 53BP1 Antibody Product Offered
Table 137. Miltenyi Biotec 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Miltenyi Biotec Main Business
Table 139. Miltenyi Biotec Latest Developments
Table 140. Biobyt Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 141. Biobyt 53BP1 Antibody Product Offered
Table 142. Biobyt 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Biobyt Main Business
Table 144. Biobyt Latest Developments
Table 145. Beyotime Details, Company Type, 53BP1 Antibody Area Served and Its Competitors
Table 146. Beyotime 53BP1 Antibody Product Offered
Table 147. Beyotime 53BP1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Beyotime Main Business
Table 149. Beyotime Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. 53BP1 Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global 53BP1 Antibody Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. 53BP1 Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. 53BP1 Antibody Sales Market Share by Country/Region (2025)
Figure 8. 53BP1 Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global 53BP1 Antibody Market Size Market Share by Type in 2025
Figure 10. 53BP1 Antibody in Immunochemistry (IHC)
Figure 11. Global 53BP1 Antibody Market: Immunochemistry (IHC) (2021-2026) & ($ millions)
Figure 12. 53BP1 Antibody in Immunofluorescence (IF)
Figure 13. Global 53BP1 Antibody Market: Immunofluorescence (IF) (2021-2026) & ($ millions)
Figure 14. 53BP1 Antibody in Immunoprecipitation (IP)
Figure 15. Global 53BP1 Antibody Market: Immunoprecipitation (IP) (2021-2026) & ($ millions)
Figure 16. 53BP1 Antibody in Western Blot (WB)
Figure 17. Global 53BP1 Antibody Market: Western Blot (WB) (2021-2026) & ($ millions)
Figure 18. 53BP1 Antibody in ELISA
Figure 19. Global 53BP1 Antibody Market: ELISA (2021-2026) & ($ millions)
Figure 20. 53BP1 Antibody in Others
Figure 21. Global 53BP1 Antibody Market: Others (2021-2026) & ($ millions)
Figure 22. Global 53BP1 Antibody Market Size Market Share by Application in 2025
Figure 23. Global 53BP1 Antibody Revenue Market Share by Player in 2025
Figure 24. Global 53BP1 Antibody Market Size Market Share by Region (2021-2026)
Figure 25. Americas 53BP1 Antibody Market Size 2021-2026 ($ millions)
Figure 26. APAC 53BP1 Antibody Market Size 2021-2026 ($ millions)
Figure 27. Europe 53BP1 Antibody Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa 53BP1 Antibody Market Size 2021-2026 ($ millions)
Figure 29. Americas 53BP1 Antibody Value Market Share by Country in 2025
Figure 30. United States 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC 53BP1 Antibody Market Size Market Share by Region in 2025
Figure 35. APAC 53BP1 Antibody Market Size Market Share by Type (2021-2026)
Figure 36. APAC 53BP1 Antibody Market Size Market Share by Application (2021-2026)
Figure 37. China 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 41. India 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe 53BP1 Antibody Market Size Market Share by Country in 2025
Figure 44. Europe 53BP1 Antibody Market Size Market Share by Type (2021-2026)
Figure 45. Europe 53BP1 Antibody Market Size Market Share by Application (2021-2026)
Figure 46. Germany 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 47. France 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 48. UK 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa 53BP1 Antibody Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa 53BP1 Antibody Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa 53BP1 Antibody Market Size Market Share by Application (2021-2026)
Figure 54. Egypt 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries 53BP1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 60. APAC 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 61. Europe 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 63. United States 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 64. Canada 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 65. Mexico 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 66. Brazil 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 67. China 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 68. Japan 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 69. Korea 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 71. India 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 72. Australia 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 73. Germany 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 74. France 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 75. UK 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 76. Italy 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 77. Russia 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 78. Egypt 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 79. South Africa 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 80. Israel 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 81. Turkey 53BP1 Antibody Market Size 2027-2032 ($ millions)
Figure 82. Global 53BP1 Antibody Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global 53BP1 Antibody Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries 53BP1 Antibody Market Size 2027-2032 ($ millions)